John Pritchard, PhD
John is now a private consultant specialising in strategic approaches to developing respiratory devices, drugs and digital health. In addition, he is a Director for a number of SMEs and sits on 3 Scientific Advisory Boards. At different stages in his career across GSK, 3M, AZ and Philips, he has worked on MDIs, DPIs and nebulized products. Along the way, he has been associated with the launch of 11 major products and at RDD in April 2018, John received the Charles Thiel award for outstanding research and discovery in respiratory drug delivery. John has published widely in the field, served as Board member on various scientific and industry bodies, as well as co-founding the DDL conference series. He is currently also a member of the UN Committee that makes recommendations on the medical uses of propellants covered by the Montreal Protocol.